Objective To review the current state of pharmaceutical treatment recommendations for the
management of osteoarthritis. Method A narrative review was drafted to describe treatment …

There are a variety of oral and topical pharmaceutical agents for the treatment of
osteoarthritis. To date there is no pharmacologic agent proved to prevent disease …

Osteoarthritis year 2010 in review: pharmacological therapies - ScienceDirect Skip to main
contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View PDF …

Opinion statement Osteoarthritis (OA) is not merely a degenerative disease but a disease of
the whole joint. The aims of OA treatment are to alleviate pain and to improve function. The …

Osteoarttiritis (OA) is the most common form of arthritis and the leading cause of disability in
the United States, especially among older adults. Treatment options have primarily focused …

Simple oral analgesics, such as acetaminophen or low dosages of nonsteroidal anti-
inflammatory drugs (NSAIDs), remain the first line of treatment for uncomplicated …

Objectives To update a previous report on the comparative benefits and harms of oral non-
steroidal anti-inflammatory drugs (NSAIDs), acetaminophen, over-the-counter supplements …

Osteoarthritis (OA) is currently defined by the American College of Rheumatology as a
“heterogeneous group of conditions that leads to joint symptoms and signs which are …

Alleviation of pain and inhibition of inflammation are the primary goals of pharmacotherapy
of osteoarthritis (OA). These therapeutic goals can almost always be accomplished by the …

Despite its growing prevalence, osteoarthritis (OA) remains a poorly understood disease,
and recent doubts about the safety of several commonly prescribed OA medications have …